home / stock / bsem / bsem news

BSEM News and Press, BioStem Technologies Inc From 10/17/18

Stock Information
Company Name: BioStem Technologies Inc
Stock Symbol: BSEM
Market: OTC
Website: biostemtechnologies.com
Menu
BSEM BSEM Quote BSEM Short BSEM News BSEM Articles BSEM Message Board
Get BSEM Alerts

News, Short Squeeze, Breakout and More Instantly...
BSEM - BioStem Technologies Selects PCG Advisory Group for Investor Relations and Strategic Communications

Pompano Beach, FL, Oct. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine, ...
BSEM - BioStem launches four amniotic products; investors unmoved, shares down 9%

Ultra-thinly traded BioStem Technologies ( OTCPK:BSEM -8.5% ) is down on light volume on the heels of its announcement that subsidiary BioStem Life Sciences is rolling out four new placental-derived products for a range of indications. More news on: BioStem Technologies, Inc., Healthca...

BSEM - BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products

Pompano Beach, FL, Oct. 01, 2018 (GLOBE NEWSWIRE) -- BioStem Life Sciences (“Life Sciences” or the “Company”), a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM), a Company focused on the development of the highest quality placental-based ...

BSEM - BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House

Pompano Beach, FL, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine...
BSEM - Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy

Pompano Beach, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on the development of novel reformulated pharmaceutical products tha...

BSEM - Nesvik Pharmaceuticals, Inc., Receives Updated U.S. FDA Establishment Registration in Light of New Product Development

Pompano Beach, FL, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on the development of novel reformulated pharmaceutical products that...

BSEM - BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements

Pompano Beach, FL., Aug. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine that exponentially improve, extend, and transform the qu...
BSEM - BioStem Technologies, Inc. Engages Maxim Group LLC For Strategic Advisory Services

Fort Lauderdale, FL, Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), (the “Company” or “BioStem Technologies”) a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regener...

BSEM - BioStem Technologies, Inc. (BSEM) Launches New Subsidiary to Engage in the Processing and Supply of Regenerative Tissue Products

Pompano Beach, FL, Aug. 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Pharmac...

BSEM - BioStem Technologies Inc. Launches Expanded Shareholder Communications Initiative

Pompano Beach, FL, Aug. 08, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine ...
Previous 10 Next 10